Avantor Inc (AVTR)

$11.64 +0.34 (3.01%)
Market Cap 7.70B
Revenue (ttm) 6.78B
Net Income (ttm) 711.50M
EPS (ttm) N/A
PE Ratio 11.36
Forward PE 11.02
Profit Margin 10.49%
Debt to Equity Ratio 0.67
Volume 18,404,600
Avg Vol 12,985,242
Day's Range N/A - N/A
Shares Out 681.43M
Stochastic %K 23%
Beta 0.96
Analysts Sell
Price Target $17.47

Company Profile

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 610 386 1700
Address:
Radnor Corporate Center, Building One Suite 200 100 Matsonford Road, Radnor, United States
NaturalFlexer
NaturalFlexer Aug. 5 at 4:30 PM
$AVTR Starting a position at $11.82
0 · Reply
FrancisHenderson887
FrancisHenderson887 Aug. 4 at 7:45 PM
$AVTR This WKSP tape is SCARY clean 🧊 No wild spikes. Just steady fkn pressure. Float tight af. Cap a fkn joke.
0 · Reply
FrancisHenderson887
FrancisHenderson887 Aug. 4 at 6:36 PM
$AVTR Institutions quietly loading WKSP 👀 Price creeping up. Volume rising. No PR. Microcap, low float, still at $3.31 - for now. You're early... or exit liquidity. Not advice - just watching whales swim.
0 · Reply
ZacksResearch
ZacksResearch Aug. 4 at 5:02 PM
$AVTR struggles continue with a 46.1% YTD drop compared to the industry's 8.5% decline! 📉 Adjusted EPS missed estimates, while revenue slightly beat. Competitive pressures and bioprocessing headwinds persist, leading to a cautious outlook for specific segments in 2025. Understand the full scope here 👉 https://www.zacks.com/stock/news/2663051/avtr-stock-declines-as-q2-earnings-miss-estimates-revenues-down-yy?cid=sm-stocktwits-2-2663051-body-5797&ADID=SYND_STOCKTWITS_TWEET_2_2663051_BODY_5797
0 · Reply
FrancisHenderson887
FrancisHenderson887 Aug. 4 at 4:50 PM
$AVTR WTF is going on in WKSP lmao +3,5% and soaking size - no PR Low float. Clean tech. Products ready. ⠀ Feels like that ''right before news hits'' accumulation 🧠 If you’re not early here, you’re exit liquidity.
0 · Reply
ZacksResearch
ZacksResearch Aug. 4 at 3:58 PM
$AVTR tanks 15% — is the worst behind it? Q2 EPS missed estimates, revenues fell year over year, and full-year guidance was cut — a triple whammy no investor wants. Full breakdown here 👉 https://www.zacks.com/stock/news/2663051/avtr-stock-declines-as-q2-earnings-miss-estimates-revenues-down-yy?cid=sm-stocktwits-2-2663051-teaser-5739&ADID=SYND_STOCKTWITS_TWEET_2_2663051_TEASER_5739
0 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 3:38 PM
JP Morgan has adjusted their stance on Avantor ( $AVTR ), setting the rating to Overweight with a target price of 17 → 14.
0 · Reply
FrancisHenderson887
FrancisHenderson887 Aug. 4 at 3:34 PM
$AVTR WKSP lighting up the tape
0 · Reply
IN0V8
IN0V8 Aug. 4 at 3:14 PM
$AVTR Barclays cuts target price to $13 from $15 Jefferies cuts to hold from buy; cuts target price to $12 from $20 Stifel cuts target price to $12 from $14 Wells Fargo cuts target price to $16 from $19
0 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 3:01 PM
Evercore ISI Group has adjusted their stance on Avantor ( $AVTR ), setting the rating to Outperform with a target price of 18 → 16.
0 · Reply
Latest News on AVTR
Avantor Q2 Feels The Impact From Bioprocessing Shortfalls, Customer Headwinds, Continued Margin Pressure

Aug 1, 2025, 2:35 PM EDT - 4 days ago

Avantor Q2 Feels The Impact From Bioprocessing Shortfalls, Customer Headwinds, Continued Margin Pressure

Avantor, Inc. (AVTR) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 10:42 AM EDT - 4 days ago

Avantor, Inc. (AVTR) Q2 2025 Earnings Call Transcript

Avantor® Reports Second Quarter 2025 Results

Aug 1, 2025, 6:05 AM EDT - 4 days ago

Avantor® Reports Second Quarter 2025 Results

Avantor Announces Emmanuel Ligner as Next President and CEO

Jul 21, 2025, 7:05 AM EDT - 15 days ago

Avantor Announces Emmanuel Ligner as Next President and CEO

Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025

Jun 27, 2025, 8:05 AM EDT - 5 weeks ago

Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025

Avantor: Unloved Lab And Medical Testing Supplier Under Heavy Accumulation

Jun 27, 2025, 12:55 AM EDT - 5 weeks ago

Avantor: Unloved Lab And Medical Testing Supplier Under Heavy Accumulation

Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

May 16, 2025, 8:30 AM EDT - 2 months ago

Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

Avantor® to Participate in Bank of America Securities 2025 Health Care Conference

May 2, 2025, 8:05 AM EDT - 3 months ago

Avantor® to Participate in Bank of America Securities 2025 Health Care Conference

Avantor Analysts Cut Their Forecasts After Q1 Results

Apr 28, 2025, 9:28 AM EDT - 3 months ago

Avantor Analysts Cut Their Forecasts After Q1 Results

Avantor: A Healthier Diagnosis As Expectations Cool

Apr 26, 2025, 5:01 AM EDT - 3 months ago

Avantor: A Healthier Diagnosis As Expectations Cool

Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift

Apr 25, 2025, 12:24 PM EDT - 3 months ago

Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift

Avantor Stock Plummets as Firm's CEO Set to Leave Amid Sales Slump, Outlook Cut

Apr 25, 2025, 11:11 AM EDT - 3 months ago

Avantor Stock Plummets as Firm's CEO Set to Leave Amid Sales Slump, Outlook Cut

Avantor, Inc. (AVTR) Q1 2025 Earnings Call Transcript

Apr 25, 2025, 10:53 AM EDT - 3 months ago

Avantor, Inc. (AVTR) Q1 2025 Earnings Call Transcript

Avantor® Announces CEO Transition

Apr 25, 2025, 6:07 AM EDT - 3 months ago

Avantor® Announces CEO Transition

Avantor® Reports First Quarter 2025 Results

Apr 25, 2025, 6:05 AM EDT - 3 months ago

Avantor® Reports First Quarter 2025 Results

Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX

Apr 1, 2025, 8:05 AM EDT - 4 months ago

Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX

Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025

Mar 28, 2025, 8:05 AM EDT - 4 months ago

Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025

Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025

Mar 17, 2025, 7:05 AM EDT - 5 months ago

Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025

Avantor® to Present at TD Cowen's 45th Annual Health Care Conference

Feb 19, 2025, 8:05 AM EST - 5 months ago

Avantor® to Present at TD Cowen's 45th Annual Health Care Conference

Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology

Feb 19, 2025, 8:03 AM EST - 5 months ago

Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology

Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript

Feb 7, 2025, 11:08 AM EST - 6 months ago

Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript

Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025

Feb 7, 2025, 9:15 AM EST - 6 months ago

Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025

Avantor® Reports Fourth Quarter and Full Year 2024 Results

Feb 7, 2025, 6:05 AM EST - 6 months ago

Avantor® Reports Fourth Quarter and Full Year 2024 Results

TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe

Feb 3, 2025, 6:00 AM EST - 6 months ago

TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe

MRVI

Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025

Jan 10, 2025, 8:05 AM EST - 7 months ago

Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025

Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 3, 2025, 8:05 AM EST - 7 months ago

Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Avantor: Durable FCF Generator Trading For Cheap

Dec 18, 2024, 4:15 AM EST - 8 months ago

Avantor: Durable FCF Generator Trading For Cheap

Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Nov 20, 2024, 8:05 AM EST - 9 months ago

Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology

Nov 20, 2024, 7:30 AM EST - 9 months ago

Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology

QSI

Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges

Nov 14, 2024, 8:05 AM EST - 9 months ago

Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges

Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors

Nov 6, 2024, 8:05 AM EST - 9 months ago

Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors

Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript

Oct 25, 2024, 2:52 PM EDT - 10 months ago

Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript

Avantor® Reports Third Quarter 2024 Results

Oct 25, 2024, 6:05 AM EDT - 10 months ago

Avantor® Reports Third Quarter 2024 Results

Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges

Oct 23, 2024, 8:05 AM EDT - 10 months ago

Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges

Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions

Oct 18, 2024, 7:35 AM EDT - 10 months ago

Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions

Avantor® Closes Previously Announced Divestiture of its Clinical Services Business

Oct 18, 2024, 7:05 AM EDT - 10 months ago

Avantor® Closes Previously Announced Divestiture of its Clinical Services Business

Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management

Sep 30, 2024, 8:05 AM EDT - 11 months ago

Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management

Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024

Sep 27, 2024, 8:05 AM EDT - 11 months ago

Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024

Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement

Sep 25, 2024, 9:05 AM EDT - 11 months ago

Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement

Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition

Sep 23, 2024, 8:05 AM EDT - 11 months ago

Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition

Broyhill's Q2 2024 Top Five Investments

Sep 13, 2024, 4:00 AM EDT - 11 months ago

Broyhill's Q2 2024 Top Five Investments

BAX FI PM

Avantor® Achieves Bronze Medal from EcoVadis for Sustainability Performance

Sep 12, 2024, 8:05 AM EDT - 11 months ago

Avantor® Achieves Bronze Medal from EcoVadis for Sustainability Performance

Avantor® to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 22, 2024, 8:05 AM EDT - 1 year ago

Avantor® to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Audax Private Equity to Acquire Avantor's Clinical Services Business

Aug 16, 2024, 10:00 AM EDT - 1 year ago

Audax Private Equity to Acquire Avantor's Clinical Services Business

Avantor® Enters into Definitive Agreement to Divest Clinical Services Business to Audax Private Equity

Aug 16, 2024, 7:35 AM EDT - 1 year ago

Avantor® Enters into Definitive Agreement to Divest Clinical Services Business to Audax Private Equity

Avantor Analysts Increase Their Forecasts After Better-Than-Expected Earnings

Jul 29, 2024, 9:11 AM EDT - 1 year ago

Avantor Analysts Increase Their Forecasts After Better-Than-Expected Earnings

Avantor Inc. (AVTR) Q2 2024 Earnings Call Transcript

Jul 26, 2024, 10:59 AM EDT - 1 year ago

Avantor Inc. (AVTR) Q2 2024 Earnings Call Transcript

Avantor® Reports Second Quarter 2024 Results

Jul 26, 2024, 6:05 AM EDT - 1 year ago

Avantor® Reports Second Quarter 2024 Results

Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600

Jul 23, 2024, 7:17 PM EDT - 1 year ago

Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600

APO HIBB QDEL SNDR SPGI

Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease

Jul 1, 2024, 8:05 AM EDT - 1 year ago

Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease

NaturalFlexer
NaturalFlexer Aug. 5 at 4:30 PM
$AVTR Starting a position at $11.82
0 · Reply
FrancisHenderson887
FrancisHenderson887 Aug. 4 at 7:45 PM
$AVTR This WKSP tape is SCARY clean 🧊 No wild spikes. Just steady fkn pressure. Float tight af. Cap a fkn joke.
0 · Reply
FrancisHenderson887
FrancisHenderson887 Aug. 4 at 6:36 PM
$AVTR Institutions quietly loading WKSP 👀 Price creeping up. Volume rising. No PR. Microcap, low float, still at $3.31 - for now. You're early... or exit liquidity. Not advice - just watching whales swim.
0 · Reply
ZacksResearch
ZacksResearch Aug. 4 at 5:02 PM
$AVTR struggles continue with a 46.1% YTD drop compared to the industry's 8.5% decline! 📉 Adjusted EPS missed estimates, while revenue slightly beat. Competitive pressures and bioprocessing headwinds persist, leading to a cautious outlook for specific segments in 2025. Understand the full scope here 👉 https://www.zacks.com/stock/news/2663051/avtr-stock-declines-as-q2-earnings-miss-estimates-revenues-down-yy?cid=sm-stocktwits-2-2663051-body-5797&ADID=SYND_STOCKTWITS_TWEET_2_2663051_BODY_5797
0 · Reply
FrancisHenderson887
FrancisHenderson887 Aug. 4 at 4:50 PM
$AVTR WTF is going on in WKSP lmao +3,5% and soaking size - no PR Low float. Clean tech. Products ready. ⠀ Feels like that ''right before news hits'' accumulation 🧠 If you’re not early here, you’re exit liquidity.
0 · Reply
ZacksResearch
ZacksResearch Aug. 4 at 3:58 PM
$AVTR tanks 15% — is the worst behind it? Q2 EPS missed estimates, revenues fell year over year, and full-year guidance was cut — a triple whammy no investor wants. Full breakdown here 👉 https://www.zacks.com/stock/news/2663051/avtr-stock-declines-as-q2-earnings-miss-estimates-revenues-down-yy?cid=sm-stocktwits-2-2663051-teaser-5739&ADID=SYND_STOCKTWITS_TWEET_2_2663051_TEASER_5739
0 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 3:38 PM
JP Morgan has adjusted their stance on Avantor ( $AVTR ), setting the rating to Overweight with a target price of 17 → 14.
0 · Reply
FrancisHenderson887
FrancisHenderson887 Aug. 4 at 3:34 PM
$AVTR WKSP lighting up the tape
0 · Reply
IN0V8
IN0V8 Aug. 4 at 3:14 PM
$AVTR Barclays cuts target price to $13 from $15 Jefferies cuts to hold from buy; cuts target price to $12 from $20 Stifel cuts target price to $12 from $14 Wells Fargo cuts target price to $16 from $19
0 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 3:01 PM
Evercore ISI Group has adjusted their stance on Avantor ( $AVTR ), setting the rating to Outperform with a target price of 18 → 16.
0 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 2:31 PM
Morgan Stanley has updated their rating for Avantor ( $AVTR ) to Equal-Weight with a price target of 12.
0 · Reply
FrancisHenderson887
FrancisHenderson887 Aug. 4 at 2:24 PM
$AVTR
0 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 2:22 PM
Barclays updates rating for Avantor ( $AVTR ) to Overweight, target set at 15 → 13.
0 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 1:24 PM
Raymond James updates rating for Avantor ( $AVTR ) to Outperform, target set at 16 → 14.
0 · Reply
ChicagoBull0780
ChicagoBull0780 Aug. 4 at 12:14 PM
$PBM $ATCH $AVTR $VERB top watchers
0 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 12:00 PM
Baird updates rating for Avantor ( $AVTR ) to Outperform, target set at 18 → 15.
0 · Reply
FrancisHenderson887
FrancisHenderson887 Aug. 4 at 11:03 AM
$AVTR WKSP mkt cap < $20M 🤯 with multi-million contracts in hand. 📊 P/S < 2, P/B < 1 - microcap value on steroids. Target: $12.83 (+300% upside). Gross margin >30% by end ‘25. Mismatch between perception & reality won’t last
0 · Reply
OptionRunners
OptionRunners Aug. 1 at 1:15 PM
$AVTR -11% on earnings
0 · Reply
mikesterz7
mikesterz7 Aug. 1 at 12:12 PM
$AVTR 🚨 🚨 🚨 Overall net sales decreased 1% year-over-year Net income declined 30% to $64.7 million from $92.9 million in Q2 2024 Laboratory Solutions segment reported 3% sales decline Bioscience Production faced challenges from planned maintenance and regulatory issues Additionally, Avantor announced a significant leadership change, with Emmanuel Ligner appointed as the new President and CEO, effective August 18, 2025, replacing Michael Stubblefield.
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 1 at 12:02 PM
$AVTR (-10.7% pre) Avantor earnings missed by $0.01, revenue topped estimates https://ooc.bz/l/72264
0 · Reply
OptionRunners
OptionRunners Jul. 28 at 2:58 PM
$AVTR Buyer of the January 16th 2026 $15 puts (ITM) 1,800 times for $2.25 ahead of earnings on 8/1
0 · Reply
JarvisFlow
JarvisFlow Jul. 28 at 12:30 PM
Baird has updated their rating for Avantor ( $AVTR ) to Outperform with a price target of 18.
0 · Reply